Medical Market Access
Pharmaceutical, biotechnology and medical device companies around the globe trust Optum™ to help them address the complex product development and commercialisation challenges they face.
With leading expertise in health economics and outcomes research and economic modelling, we develop and implement strategic study designs and health technology assessments that combine scientific and commercial objectives to help maximise the opportunities for your products in the marketplace.
Develop Comprehensive, Flexible Strategies for Enduring Success
Market access and reimbursement
At Optum, our Market Access and Reimbursement Group is focused on providing clients with the comprehensive research and strategy development needed to address payer, government and health technology assessment (HTA) agency requirements for payer coverage and reimbursement. With expertise in dossier preparation (including PBAC, MSAC, RPRC, PHARMAC), meta-analyses, indirect comparisons, health policy assessments, clinical practice guideline development and strategic plan development, we provide the insight and strategies that can help you successfully demonstrate the value of your products to all stakeholders in order to maximise your marketplace opportunities.
The Optum team has an outstanding track record in the development of economic models to support pricing, reimbursement and market access. We can develop global models with the flexibility to accommodate epidemiologic and health care data across multiple geographies. This lets a single model platform serve multiple regions. User-friendly interfaces can overlay complex model engines to simplify use in medical marketing, physician medical education or sales force activities.
Solving the rare disease funding dilemmaIt may be time to balance funding of rare disease therapies against financial sustainability — in a manner that reflects how Australians value equity in health care.
Managing future expenditure on new medicinesGiven the rising costs of medicines and increased life expectancy, it may be time for Australia to consider a budget cap for new medicines.
Global Health Economics and Outcomes ResearchMaximize the opportunities for your products in the marketplace.
Creating a sustainable PBSAs the costs of drugs continue to grow, so too do the options for reforming the PBS.
Connecting for better health
How do we ensure that health information available via the Internet is useful and credible to consumers?
For information about corporate headquarters and careers at Optum.
For more information about how to help you to enhance your positive mental health, resiliency and work life balance.
For more information about how to improve employee relations, productivity and wellbeing in your workplace.
For more information about health economics and outcomes research and economic modelling.